PD L1 News and Research

RSS
Evidence-based clinical practice guideline aims to optimize PD-L1 lung tumor testing

Evidence-based clinical practice guideline aims to optimize PD-L1 lung tumor testing

Objectives, challenges and opportunities of new IASLC Molecular Database Project

Objectives, challenges and opportunities of new IASLC Molecular Database Project

Researchers explore a case of diabetic ketoacidosis in patient with atezolizumab-induced autoimmune diabetes

Researchers explore a case of diabetic ketoacidosis in patient with atezolizumab-induced autoimmune diabetes

Checkpoint inhibition could offer an effective treatment option for patients with rare cancer

Checkpoint inhibition could offer an effective treatment option for patients with rare cancer

Study characterizes shifting neoantigen burden between primary and metastatic tumors within HNSCC

Study characterizes shifting neoantigen burden between primary and metastatic tumors within HNSCC

Phase 3 DREAM3R trial opens for malignant pleural mesothelioma

Phase 3 DREAM3R trial opens for malignant pleural mesothelioma

Studies reveal how kidney tumors' microenvironments change in response to immunotherapy

Studies reveal how kidney tumors' microenvironments change in response to immunotherapy

Immune cells in cerebrospinal fluid could be novel biomarkers of response to immune-based therapies

Immune cells in cerebrospinal fluid could be novel biomarkers of response to immune-based therapies

Compound isolated from Moroccan fungus shows promise to fight triple negative breast cancer

Compound isolated from Moroccan fungus shows promise to fight triple negative breast cancer

Newly identified biomarker could predict response to immune checkpoint inhibitors

Newly identified biomarker could predict response to immune checkpoint inhibitors

PICI awards $3 million to support early career cancer researchers

PICI awards $3 million to support early career cancer researchers

Sequential administration of immunotherapy and targeted therapy prolongs anti-tumor responses

Sequential administration of immunotherapy and targeted therapy prolongs anti-tumor responses

New technique uncovers the tricks used by cancer cells to evade immunotherapies

New technique uncovers the tricks used by cancer cells to evade immunotherapies

Combination therapy produces clinical benefit for early stage non-small cell lung cancer

Combination therapy produces clinical benefit for early stage non-small cell lung cancer

Study: Targeted therapy prolongs survival in patients with advanced bladder cancer

Study: Targeted therapy prolongs survival in patients with advanced bladder cancer

POSTECH researchers discover mechanism behind intestinal epithelial lymphocyte differentiation

POSTECH researchers discover mechanism behind intestinal epithelial lymphocyte differentiation

Tiny molecular motions are of key significance in modern anti-cancer drugs

Tiny molecular motions are of key significance in modern anti-cancer drugs

Researchers engineer "Nanotraps" that block SARS-CoV-2 infection

Researchers engineer "Nanotraps" that block SARS-CoV-2 infection

Nivolumab monotherapy is effective treatment option for relapsed malignant mesothelioma

Nivolumab monotherapy is effective treatment option for relapsed malignant mesothelioma

Substances in tick saliva activate immune response-suppressing proteins in cattle

Substances in tick saliva activate immune response-suppressing proteins in cattle

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.